{"id":"placebo-for-tamsulosin","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance used as a control in clinical trials to establish the efficacy of an active drug by comparison. It relies on the placebo effect—the psychological and physiological response to the expectation of treatment—rather than any direct molecular mechanism. In this Phase 3 trial, placebo serves as the comparator arm against Tamsulosin, an alpha-1A adrenergic receptor antagonist used for benign prostatic hyperplasia.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:32.509Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 trial for benign prostatic hyperplasia (comparison to Tamsulosin)"}]},"trialDetails":[{"nctId":"NCT04491526","phase":"PHASE4","title":"Study to Prevent Postoperative Urinary Retention","status":"TERMINATED","sponsor":"Antonio Nocito, MD","startDate":"2020-11-01","conditions":"Urinary Retention, Inguinal Hernia","enrollment":312},{"nctId":"NCT03229889","phase":"PHASE4","title":"Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2017-06-07","conditions":"Nephrolithiasis","enrollment":220},{"nctId":"NCT07174349","phase":"PHASE4","title":"Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-02-01","conditions":"Urinary Retention Postoperative","enrollment":20},{"nctId":"NCT05415748","phase":"PHASE4","title":"Deprescribing Tamsulosin in Older Men","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-09-18","conditions":"Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms","enrollment":31},{"nctId":"NCT04232683","phase":"EARLY_PHASE1","title":"Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2019-12-18","conditions":"Urinary Retention","enrollment":100},{"nctId":"NCT06843538","phase":"PHASE3","title":"Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery","status":"RECRUITING","sponsor":"TriHealth Inc.","startDate":"2025-02-03","conditions":"Postoperative Urinary Retention (POUR)","enrollment":166},{"nctId":"NCT01018511","phase":"PHASE3","title":"Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2010-01-11","conditions":"Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms","enrollment":1334},{"nctId":"NCT02656173","phase":"PHASE4","title":"A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2016-01-25","conditions":"Overactive Bladder","enrollment":568},{"nctId":"NCT02757768","phase":"PHASE4","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2016-06-13","conditions":"Benign Prostatic Hyperplasia, Overactive Bladder","enrollment":715},{"nctId":"NCT02038868","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2013-07-22","conditions":"Benign Prostate Hyperplasia","enrollment":320},{"nctId":"NCT05439902","phase":"NA","title":"Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2022-10-05","conditions":"Multiple Sclerosis, Dysuria, Lower Urinary Tract Symptoms","enrollment":60},{"nctId":"NCT06124066","phase":"PHASE4","title":"THE EFFECTS OF MIRABEGRON AND TAMSULOSIN FOR PATIENTS WITH URETERAL STENTS","status":"COMPLETED","sponsor":"Hasanuddin University","startDate":"2022-07-01","conditions":"Ureteral Stone, Kidney Stones, Ureteral Stenosis","enrollment":42},{"nctId":"NCT05945420","phase":"PHASE4","title":"Adding Desmopressin to Tamsulosin for Treatment of BPH","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2023-07-20","conditions":"Nocturnal Polyurea in Patients With BPH","enrollment":160},{"nctId":"NCT05941806","phase":"PHASE3","title":"Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection","status":"UNKNOWN","sponsor":"CHU de Quebec-Universite Laval","startDate":"2023-08-01","conditions":"Urinary Retention, Colorectal Surgery, Rectal Resection","enrollment":220},{"nctId":"NCT05759767","phase":"NA","title":"The Efficacy and Safety of Medical Expulsive Therapy After Extracorporeal Shock Wave Lithotripsy (ESWL) in Pediatric Urolithiasis","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-02-01","conditions":"Tamsulosin, Extracorporeal Shock Wave Lithotripsy, Stone, Kidney","enrollment":120},{"nctId":"NCT05551221","phase":"PHASE4","title":"The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia","status":"RECRUITING","sponsor":"Xintian Pharmaceutical","startDate":"2022-07-18","conditions":"Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms","enrollment":312},{"nctId":"NCT02003742","phase":"PHASE3","title":"Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH","status":"TERMINATED","sponsor":"RECORDATI GROUP","startDate":"2013-09","conditions":"Lower Urinary Tract Symptoms","enrollment":104},{"nctId":"NCT02919436","phase":"PHASE4","title":"Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery","status":"COMPLETED","sponsor":"Anand Rughani, MD","startDate":"2016-03","conditions":"Post-operative Urinary Retention","enrollment":610},{"nctId":"NCT03976934","phase":"PHASE1, PHASE2","title":"Prophylactic Administration of Alpha Blockers for Prevention of Urinary Retention in Males Undergoing Inguinal Hernia Repair Under Spinal Anaesthesia.","status":"COMPLETED","sponsor":"Georgios Koukoulis","startDate":"2020-02-01","conditions":"Inguinal Hernia, Urinary Retention","enrollment":100},{"nctId":"NCT04325880","phase":"PHASE3","title":"Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-12-01","conditions":"Ureteral Stent, Stent Related Symptoms","enrollment":240},{"nctId":"NCT03524339","phase":"PHASE2, PHASE3","title":"Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2018-08-01","conditions":"Urinary Retention, Lower Urinary Tract Symptoms, Stress Urinary Incontinence","enrollment":132},{"nctId":"NCT01589263","phase":"PHASE2","title":"Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2012-06-01","conditions":"Benign Prostatic Hyperplasia, Lower Urinary Track Symptoms","enrollment":63},{"nctId":"NCT05032287","phase":"NA","title":"Medical Expulsive Therapy Post-SWL For Renal Stones","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2019-09-01","conditions":"Urologic Diseases, Urolithiasis, Stone, Kidney","enrollment":235},{"nctId":"NCT03314025","phase":"PHASE2","title":"Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery","status":"UNKNOWN","sponsor":"CHU de Quebec-Universite Laval","startDate":"2017-10-06","conditions":"Urinary Retention","enrollment":158},{"nctId":"NCT02279615","phase":"PHASE4","title":"Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.","status":"UNKNOWN","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2021-12","conditions":"Overactive Bladder, Benign Prostatic Hyperplasia","enrollment":200},{"nctId":"NCT04557202","phase":"PHASE3","title":"Effect of Perioperative Selective alpha1-blockers in Non-stented Ureteroscopic Laser Lithotripsy for Ureteric Stones: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2017-09-01","conditions":"Non-stented Ureteroscopic Laser Lithotripsy for Ureteric Stones","enrollment":120},{"nctId":"NCT04418635","phase":"NA","title":"Herbal Supplement Prosta-OK® Neo as an Adjunct Therapy in Patients With Mild to Severe Non-neurogenic Male Lower Urinary Tract Symptoms Receiving Tamsulosin Therapy","status":"UNKNOWN","sponsor":"Acrobio Healthcare Inc.","startDate":"2020-06-04","conditions":"Lower Urinary Tract Symptoms","enrollment":100},{"nctId":"NCT03614052","phase":"PHASE4","title":"Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy","status":"TERMINATED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2018-06-01","conditions":"Ureterolithiasis, Ureteral Calculi, Urolithiasis","enrollment":14},{"nctId":"NCT02486653","phase":"PHASE3","title":"Prevention of Post-operative Urinary Retention","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2015-08","conditions":"Urinary Retention, Urinary Tract Infections","enrollment":158},{"nctId":"NCT03600766","phase":"PHASE2","title":"Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2018-08-01","conditions":"BPH, Erectile Dysfunction, Prostate Hyperplasia","enrollment":50},{"nctId":"NCT02972268","phase":"PHASE3","title":"Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH","status":"COMPLETED","sponsor":"Jeil Pharmaceutical Co., Ltd.","startDate":"2016-02-01","conditions":"Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia","enrollment":780},{"nctId":"NCT02958878","phase":"PHASE4","title":"Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia Repair","status":"COMPLETED","sponsor":"Ascension Health","startDate":"2017-01-03","conditions":"Postoperative Urinary Retention","enrollment":210},{"nctId":"NCT01741454","phase":"PHASE4","title":"Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2012-11","conditions":"Ureteral Obstruction","enrollment":181},{"nctId":"NCT02518971","phase":"PHASE3","title":"Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients","status":"TERMINATED","sponsor":"University of Michigan","startDate":"2015-08","conditions":"Postoperative Urinary Retention","enrollment":176},{"nctId":"NCT02058368","phase":"PHASE3","title":"Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-02-10","conditions":"Prostatic Hyperplasia","enrollment":607},{"nctId":"NCT03799120","phase":"PHASE4","title":"Daily Versus Twice Per Day Tamsulosin for Ureteral Stent Symptoms","status":"UNKNOWN","sponsor":"Gundersen Lutheran Medical Foundation","startDate":"2019-02-18","conditions":"Ureteral Diseases","enrollment":80},{"nctId":"NCT00457457","phase":"PHASE2","title":"Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2007-05","conditions":"Prostatic Hyperplasia","enrollment":609},{"nctId":"NCT00382265","phase":"PHASE4","title":"Tamsulosin for Urolithiasis in the Emergency Dept","status":"COMPLETED","sponsor":"Andrew Meltzer","startDate":"2008-01","conditions":"Ureterolithiases","enrollment":512},{"nctId":"NCT01534351","phase":"PHASE3","title":"Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2013-08-01","conditions":"Benign Prostatic Hyperplasia","enrollment":1},{"nctId":"NCT01777269","phase":"PHASE4","title":"Prospective Sexual Function Study for BPH Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-02-18","conditions":"Prostatic Hyperplasia","enrollment":489},{"nctId":"NCT03314259","phase":"EARLY_PHASE1","title":"Prophylactic Alpha-blockers in the Prevention of Urinary Retention Post Inguinal Hernia Repair","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2017-12-01","conditions":"Urinary Retention, Inguinal Hernia","enrollment":300},{"nctId":"NCT03274700","phase":"EARLY_PHASE1","title":"The Use of Tamsulosin in Treatment of (10-15 mm) Lower Ureteric Stones in Adults With Non-emergent Symptoms","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-10-01","conditions":"Ureteric Stone","enrollment":80},{"nctId":"NCT01937871","phase":"PHASE3","title":"A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-09","conditions":"Benign Prostate Hyperplasia, Erectile Dysfunction","enrollment":909},{"nctId":"NCT02862483","phase":"PHASE3","title":"The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction","status":"UNKNOWN","sponsor":"IlDong Pharmaceutical Co Ltd","startDate":"2016-03","conditions":"Benign Prostatic Hyperplasia, Erectile Dysfunction","enrollment":330},{"nctId":"NCT00796614","phase":"PHASE2, PHASE3","title":"Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2008-01","conditions":"Bladder, Neurogenic","enrollment":231},{"nctId":"NCT01830829","phase":"PHASE3","title":"JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)","status":"TERMINATED","sponsor":"Dr. J. Curtis Nickel","startDate":"2013-04","conditions":"Benign Prostatic Hyperplasia, Chronic Prostatitis","enrollment":1},{"nctId":"NCT01747993","phase":"PHASE3","title":"Tamsulosin for Urinary Retention in Hospitalized Older Women","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-01","conditions":"Urinary Retention","enrollment":34},{"nctId":"NCT00333112","phase":"PHASE4","title":"A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2006-05","conditions":"Urinary Incontinence","enrollment":398},{"nctId":"NCT02169713","phase":"PHASE1","title":"Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2014-05","conditions":"Healthy Subjects, Pharmacokinetics, Drug-Drug Interaction (DDI)","enrollment":20},{"nctId":"NCT00507455","phase":"PHASE2","title":"Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2007-06","conditions":"Lower Urinary Tract Symptoms, Bladder Outlet Obstruction","enrollment":222},{"nctId":"NCT00209131","phase":"NA","title":"Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy","status":"TERMINATED","sponsor":"Emory University","startDate":"2005-04","conditions":"Urolithiasis","enrollment":24},{"nctId":"NCT00771394","phase":"PHASE4","title":"Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2008-10","conditions":"Benign Prostatic Hyperplasia, Benign Prostatic Hypertrophy, Overactive Bladder","enrollment":638},{"nctId":"NCT00970632","phase":"PHASE3","title":"A Study of Tadalafil in Men With Benign Prostatic Hyperplasia","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-10","conditions":"Benign Prostatic Hyperplasia (BPH)","enrollment":511},{"nctId":"NCT00861757","phase":"PHASE3","title":"Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-03","conditions":"Benign Prostatic Hyperplasia","enrollment":612},{"nctId":"NCT00338624","phase":"PHASE3","title":"An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.","status":"COMPLETED","sponsor":"McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.","startDate":"2004-05","conditions":"Urination Disorders","enrollment":420},{"nctId":"NCT00244309","phase":"PHASE3","title":"Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2005-11","conditions":"Prostate Cancer","enrollment":348},{"nctId":"NCT01100021","phase":"PHASE1","title":"Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and Tamsulosin","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2010-02","conditions":"Erectile Dysfunction","enrollment":48},{"nctId":"NCT00540124","phase":"PHASE2","title":"Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2007-10","conditions":"Benign Prostatic Hyperplasia","enrollment":151},{"nctId":"NCT01215708","phase":"PHASE3","title":"Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal Calculus","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2006-08","conditions":"Renal Calculi","enrollment":136},{"nctId":"NCT01167062","phase":"PHASE4","title":"Efficacy of Tamsulosin Oral-controlled Absorption System (OCAS) in the Treatment of Distal Ureteral Stones","status":"UNKNOWN","sponsor":"Chiang Mai University","startDate":"2010-06","conditions":"Ureteral Calculi","enrollment":120},{"nctId":"NCT00831701","phase":"NA","title":"Medical Expulsive Therapy of Single Distal Ureteral Stones","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2006-09","conditions":"Ureteral Calculi","enrollment":100},{"nctId":"NCT00913315","phase":"NA","title":"Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic Prostatitis","status":"UNKNOWN","sponsor":"Chongqing Medical University","startDate":"2009-08","conditions":"Prostatitis","enrollment":30},{"nctId":"NCT00359905","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH","status":"COMPLETED","sponsor":"RECORDATI GROUP","startDate":"2006-05","conditions":"Benign Prostatic Hyperplasia","enrollment":1228}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":389,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo for Tamsulosin","genericName":"Placebo for Tamsulosin","companyName":"IlDong Pharmaceutical Co Ltd","companyId":"ildong-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect. Used for Control arm in Phase 3 trial for benign prostatic hyperplasia (comparison to Tamsulosin).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}